Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol.
Fiche publication
Date publication
juillet 2024
Journal
The Cochrane database of systematic reviews
Auteurs
Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie
Tous les auteurs :
Marchal C, Orillard E, Calais F, Westeel V
Lien Pubmed
Résumé
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICI) as monotherapy or in combination compared to standard of care for elderly people (≥ 65 years) with non-small cell lung cancer (NSCLC).
Mots clés
Humans, Carcinoma, Non-Small-Cell Lung, therapy, Lung Neoplasms, therapy, Aged, Immune Checkpoint Inhibitors, therapeutic use, Immunotherapy, methods, Systematic Reviews as Topic, Randomized Controlled Trials as Topic, Standard of Care
Référence
Cochrane Database Syst Rev. 2024 07 3;7(7):CD014907